Evidence map›Paper›PMID 34967258›Full record

ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2023

Clinical impact of Sim & Size

Daniel Mantilla, Carlos A Ferreira-Prada, Melquisedec Galvis, Oliverio Vargas, Carolina Valenzuela-Santos, Piergiorgio Canci, Miguel Ochoa, Franck Nicoud, Vincent Costalat

Open access · greenAbstract read
In one paragraph

Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Daniel MantillaInstitut Montpelliérain Alexander, Grothendieck, Univ. Montpellier, Montpellier, France.ORCID 0000-0002-5727-3195
Carlos A Ferreira-PradaInterventional radiology Department. Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.ORCID 0000-0002-7068-356X
Melquisedec GalvisInterventional radiology Department. Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
Oliverio VargasInterventional radiology Department. Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
Carolina Valenzuela-SantosPhysician. Radiology Deparment, 536071Fundación oftalmológica de Santander, Clínica Ardila Lülle, Floridablanca, Colombia.ORCID 0000-0002-2894-5087
Piergiorgio CanciApplication Engineer, Sim&Cure, Montpellier, France.
Miguel OchoaClinical Research Group-UNAB, 27968Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
Franck NicoudInstitut Montpelliérain Alexander, Grothendieck, CNRS, Univ. Montpellier, Montpellier, France.
Vincent CostalatNeuroradiology. Hôpital Güi-de-Chauliac, 26905CHU de Montpellier, Montpellier, France.
Universidad Autónoma de Bucaramanga · COCentre National de la Recherche Scientifique · FRFoscal Hospital · COHôpital Gui de Chauliac · FRMontpellier GenomiX · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study evaluated the clinical impact of the Sim&Size® simulation software on the endovascular treatment with flow-diverter stents of patients with unruptured saccular intracranial aneurysms.

methodsThis monocentric retrospective study evaluated a cohort of patients treated with flow-divert stents between June 1, 2014, and December 31, 2019, for cerebral aneurysms. Patients belonged to two groups, patients treated with and without the Sim&Size® simulation software. Univariate, bivariate, and multivariate analyses were used to evaluate the clinical impact of simulation software.

resultsOut of the 73 interventions involving 68 patients analyzed by the study, 76.7% were simulated using the Sim&Size® simulation software, and 23.3% were not. Patients treated with the simulation software had shorter stent lengths (16.00 mm vs. 20.00 mm

conclusionsUsing the Sim&Size® simulation software for the endovascular treatment of intracranial aneurysms with pipeline flow-diverter stents reduces the stent length.

Indexed as

Embolization, TherapeuticEndovascular ProceduresIntracranial AneurysmCerebral AngiographyHumansRetrospective StudiesSoftwareStentsTreatment OutcomeArtificial IntelligenceComputer SimulationEndovascular ProceduresFlow-Diverter DevicesIntracranial AneurysmPipeline Embolization Device

Identifiers

PMID34967258
PMCPMC9893244
OpenAlexW4200291085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.